Trial Profile
Compassionate use study of midostaurin in adult patients with aggressive systemic mastocytosis (ASM), mast cell leukemia (MCL) or mast cell sarcoma (MCS)
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Midostaurin (Primary)
- Indications Acute myeloid leukaemia; Mast Cell Leukemia; Sarcoma; Systemic mastocytosis
- Focus Therapeutic Use
- 19 Apr 2017 Results (n=38) evaluating the impact of molecular markers (KIT D816V, S/A/Rpos) at baseline and during follow-up in midostaurin-treated advSM patients using patient data from this and NCT00782067 trial, published in the Blood
- 09 Aug 2016 New trial record